Document text
Centers for Disease Control and Prevention
National Center for Immunization and Respiratory Diseases
Photographs and images included in this presentation are licensed solely for CDC/NCIRD online and presentation
use. No rights are implied or extended for use in printing or any use by other CDC CIOs or any external audiences.
Implementation Update on
2023 –2024 COVID -19 Vaccines
Shannon Stokley, DrPH
Immunization Services Division
Centers for Disease Control and Prevention
Commercialization Transition
▪The CDC COVID -19 Vaccination Program discontinued on:
–September 12, 2023, as applied to the bivalent Moderna and Pfizer -BioNTech
COVID -19 vaccines
–October 3, 2023, as applied to the ancestral (Original) Novavax COVID -19 Vaccine
▪Providers are encouraged to:
–Continue administering COVID -19 vaccine through their offices/pharmacies/other
practices
–Participate in vaccines.gov
▪Vaccine data reporting has transitioned to routine reporting processes for
jurisdictions that have signed data use agreement (DUA) with CDC.U.S. Government Vaccination Program Discontinuation
▪Updated COVID -19 vaccines are available to most people living in the U.S.
at no cost through their private health insurance, Medicare, and Medicaid
plans.Vaccine Cost/Insurance
*Adults with health insurance that does not cover all COVID -19 vaccine costs, at any Bridge Access Program site which is in-network for their health insurance.Private health
insurance
Plans that are ACA -
compliant c over COVID -
19 vaccines from an in -
network provider at no
cost -sharing.Medicare and Medicaid
Cover COVID -19
vaccines at no -cost
sharingGovernment programs
Provide vaccine at no cost for:
•VFC: Children through 18 years that
are Medicaid eligible, uninsured,
American Indian/Alaska Native, or
underinsured
•Bridge Access Program: Adults ages
18 years and older who are
underinsured* or uninsured
▪There is increasing supply of vaccine to meet demand.
–Moderna, Pfizer -BioNTech, and Novavax are available.
▪CDC is continuing to have conversations with manufacturer and
distributors to ensure timely distribution of COVID -19 vaccines.
▪Visit vaccines.gov to find a COVID -19 vaccine near you.Vaccine Availability
Bridge Access Program
▪CDC’s Bridge Access Program provides no -cost COVID -19 vaccines to
adults without health insurance and adults whose insurance does not
cover all COVID -19 vaccination costs.
–All CDC -recommended COVID -19 vaccines are included in the Bridge Access
Program.
–The Bridge Access Program will end by December 31, 2024.
–The Vaccines for Adults (VFA) program, proposed in the FY 2023 and 2024
Presidential Budget, would be a long -term solution to ensure all adults have access
to recommend vaccinations, including COVID -19 vaccines, at no cost to them.CDC’s Bridge Access Program
Adults 18 years and older without health insurance
-and -
Adults with health insurance that does not cover all COVID -19
vaccine costs (only at Bridge Access Program sites that are in-
network for their health insurance)Who Can Get a No -Cost COVID -19 Vaccine Through the
Bridge Program
Where to Get a No -Cost COVID -19 Vaccine through the
Bridge Access Program?
Visit Vaccines.gov to find a provider that offers no -cost COVID -19
vaccines through the Bridge Access Program!
Community
events or
pop-up sites
with these
groups
Local Healthcare Providers
Retail Pharmacies:
Walgreens, CVS, eTrueNorth (pharmacy aggregator)HRSA -Supported Centers
Bridge Program Ordering and Administration*
*Data as of 10/20/2023
There are >24,000 contracted pharmacy locations and
>380,000 doses have been administered by contracted
pharmacies to individuals without insurance in the U.S.Rx
>4,400 public health safety net providers have placed >6,100
orders for > 287,000 doses of COVID -19 vaccine using 317 funds.
Nationally, 81% of people without insurance are estimated to be
within a 5-mile drive distance to a Bridge Access Program provider.
Vaccination Coverage
Snapshot of COVID -19 vaccine data reporting plans
Administration data from reporting states National Immunization Surveys
Bridge Access Program for COVID -19 Vaccines
Other surveillance systems
Vaccine Safety Datalink
Other data sources
Omnibus surveys
Internet panel survey of pregnant people
Distribution data
National Healthcare
Safety Network
Among 14,715 adults ages 18 years and older, 7.1% reported having
received a COVID -19 vaccine since September 14, 2023.
COVID -19 Vaccination Status and Intent Among Adults Age ≥18 Years by Demographics,
National Immunization Survey -Adult COVID Module, October 8 –14, 2023
Probably or definitely will NOT get vaccinatedUp to date with 2023 -24 COVID -19 vaccine
Definitely will get vaccinated
Probably will get vaccinated or unsure0.88.110.23.57.68.34.64.97.08.22.32.64.77.515.420.56.57.77.1
31.215.123.219.323.927.224.422.924.525.516.520.323.928.730.836.222.327.024.6
21.535.227.946.139.623.151.926.530.732.035.733.035.426.026.025.930.930.430.6
46.541.638.731.228.941.419.145.737.834.345.544.135.937.827.717.440.334.937.6
0 25 50 75 100AI/ANMulti/OtherNH/OPI**HispanicBlackWhiteAsianRuralSuburbanUrban18-2930-3940-4950-6465-7475+MaleFemaleOverall
Weighted %12.57.04.77.27.14.05.89.01.77.8
31.124.635.224.518.818.424.930.215.226.2
35.230.431.229.434.244.531.323.944.028.9
21.238.028.938.839.933.138.136.839.137.1
0 25 50 75 100Transgender/NonbinaryCisgenderGay/Lesbian/Bisexual/OtherStraightIncome unknownBelow povertyAbove poverty, <$75kAbove poverty, ≥$75kNot insuredInsured
Weighted %
Receipt of a COVID -19 vaccine was more frequently reported among
adults who were older, insured, and with higher incomes.
COVID -19 Vaccination Status and Intent Among Adults Age ≥18 Years by Demographics,
National Immunization Survey -Adult COVID Module, October 8 –14, 2023
Probably or definitely will NOT get vaccinatedUp to date with 2023 -24 COVID -19 vaccine
Definitely will get vaccinated
Probably will get vaccinated or unsure0.88.110.23.57.68.34.64.97.08.22.32.64.77.515.420.56.57.77.1
31.215.123.219.323.927.224.422.924.525.516.520.323.928.730.836.222.327.024.6
21.535.227.946.139.623.151.926.530.732.035.733.035.426.026.025.930.930.430.6
46.541.638.731.228.941.419.145.737.834.345.544.135.937.827.717.440.334.937.6
0 25 50 75 100AI/ANMulti/OtherNH/OPI**HispanicBlackWhiteAsianRuralSuburbanUrban18-2930-3940-4950-6465-7475+MaleFemaleOverall
Weighted %12.57.04.77.27.14.05.89.01.77.8
31.124.635.224.518.818.424.930.215.226.2
35.230.431.229.434.244.531.323.944.028.9
21.238.028.938.839.933.138.136.839.137.1
0 25 50 75 100Transgender/NonbinaryCisgenderGay/Lesbian/Bisexual/OtherStraightIncome unknownBelow povertyAbove poverty, <$75kAbove poverty, ≥$75kNot insuredInsured
Weighted %
2.12.72.70.72.22.41.42.1
0 2 4 6 8 10Other/multiple races, non-HispanicBlack, non-HispanicWhite, non-HispanicHispanic12-17 years5-11 years6 months-4 yearsAll children
Percent2.1% of children were reported to have received the updated 2023 -24
COVID -19 vaccination since it was recommended on September 14th,
2023.2023 -24 COVID -19 Vaccination Coverage,
Children Ages 6 Months -17 Years, National Immunization Survey -Child Covid Module (NIS -CCM)
Interviews week of: 10/8/2023 -10/14/2023 (n=2,767)
3.10.81.52.71.40.92.80.83.1
0 2 4 6 8 10UninsuredOther insuranceAny MedicaidRuralSuburbanUrbanUnknown incomeBelow povertyAbove poverty, <$75,000/yearAbove poverty, >=$75,000/year
Percent
Parents’ intent to get their child vaccinated was mixed.
Percentages vaccinated are all <3% and do not show well on this slide, please see previous slide.
2023 -24 COVID -19 Vaccination Coverage and Parental Intent,
Children Ages 6 Months -17 Years, National Immunization Survey -Child Covid Module (NIS -CCM)
Interviews week of: 10/8/2023 -10/14/2023 (n=2,767)
25.430.525.326.529.225.823.226.4
41.939.927.440.136.630.934.733.8
30.626.944.632.732.040.940.737.7
0 20 40 60 80 100Other/multiple races, non-HispanicBlack, non-HispanicWhite, non-HispanicHispanic12-17 years5-11 years6 months-4 yearsAll children
Percent23.728.025.219.524.831.720.023.522.432.5
33.032.933.020.234.937.641.930.433.431.2
43.336.040.958.837.629.437.343.443.433.2
0 20 40 60 80 100UninsuredOther insuranceAny MedicaidRuralSuburbanUrbanUnknown incomeBelow povertyAbove poverty, <$75,000/yearAbove poverty, >=$75,000/year
Percent
▪NIS data collected October 8 -14, 2023 provides estimates about four weeks since the
September 14, 2023 rollout of the 2023 -24 COVID -19 vaccine
▪Children (6 months –17 years)
–2.1% (95% CI: 1.1 -3.0) of children had received the updated 2023 -24 COVID -19 vaccine
–Slightly more than a quarter of children (33.8%, 95% CI: 30.6 -37.1) have a parent who said they
definitely will get their child vaccinated while 2 in 5 children (37.7%, 95% CI: 34.4 -41.0) have a parent
that said they probably or definitely will not get their child vaccinated
▪Adults (≥18 years)
–7.1% (95% CI: 6.3 -8.0) of adults had received the updated 2023 -24 COVID -19 vaccine
–24.6% (95% CI: 23.0 -26.2) of adults said they definitely will get vaccinated, and 37.6% (95% CI: 35.7 -
39.5) said they probably or definitely will not get vaccinatedCOVID Vaccination Coverage Summary
For more information, contact CDC
1-800 -CDC -INFO (232 -4636)
TTY: 1 -888 -232-6348 www.cdc.gov
The findings and conclusions in this report are those of the authors and do not necessarily represent the official
position of the Centers for Disease Control and Prevention.
Photographs and images included in this presentation are licensed solely for CDC/NCIRD online and presentation
use. No rights are implied or extended for use in printing or any use by other CDC CIOs or any external audiences.